Current Research
Molecular Genetic Approaches to Cancer Therapies and Diagnostics
Daniel Haber wants to understand the fundamental genetics of human cancers, as a rationale for the development of novel targeted therapies and diagnostic approaches. Haber and his team work to identify and characterize inherited or acquired mutations that may render tumors susceptible to targeted drug therapies. They also collaborate with other teams to develop, characterize, and apply new technologies capable of isolating rare circulating tumor cells in cancer patients. Such technologies may help monitor for the emergence of drug resistance, improve early detection of invasive cancers, and advance knowledge and prevention of blood-borne spread of cancer.